EPISODE · Jul 16, 2025 · 1H
Ep 341 | Government Is Captured by the Pharma Lobby | Guest: Del Bigtree
from Kibbe on Liberty · host Blaze Podcast Network
Typically, Americans on the political Left worry about corporate power while those on the Right worry about government power. But the real danger is when corporations and government collude to dictate how you ought to live. We saw this during COVID, when experimental vaccines were pushed onto the American people, earning pharma companies big profits while they were shielded from any liability for the harm their products may cause. At this year’s FreedomFest in Palm Springs, Matt Kibbe caught up with Del Bigtree, host of “The HighWire,” who has devoted most of his career to researching the vaccine industry. He points out that the pharma lobby is more powerful than the banks or even defense contractors and that they effectively control much of what our government does, meaning that our system is neither as capitalist nor as democratic as we imagine.
What this episode covers
Typically, Americans on the political Left worry about corporate power while those on the Right worry about government power. But the real danger is when corporations and government collude to dictate how you ought to live. We saw this during COVID, when experimental vaccines were pushed onto the American people, earning pharma companies big profits while they were shielded from any liability for the harm their products may cause. At this year’s FreedomFest in Palm Springs, Matt Kibbe caught up with Del Bigtree, host of “The HighWire,” who has devoted most of his career to researching the vaccine industry. He points out that the pharma lobby is more powerful than the banks or even defense contractors and that they effectively control much of what our government does, meaning that our system is neither as capitalist nor as democratic as we imagine.
NOW PLAYING
Ep 341 | Government Is Captured by the Pharma Lobby | Guest: Del Bigtree
No transcript for this episode yet
Similar Episodes
Apr 22, 2025 ·32m
Feb 27, 2025 ·0m
Sep 20, 2024 ·57m
Aug 7, 2024 ·16m